Pages

Showing posts with label Disease genes. Show all posts
Showing posts with label Disease genes. Show all posts

Tuesday, 26 June 2012

Exome sequencing as potential diagnostic tool in Charcot-Marie-Tooth

Exome sequencing has proved itself as a valuable tools for rapid molecular diagnosis, particularly when a disease can be caused by several mutations in different genes. Here is a good example of applying WES to discover new mutations in CMT patients with no mutations in the main disease associated loci.

Byung-Ok Choi, Soo Kyung Koo, Mi-Hyun Park, Hwanseok Rhee, Song-Ju Yang, Kyoung-Gyu Choi, Sung-Chul Jung, Han Su Kim, Young Se Hyun, Khriezhanuo Nakhro, Hye Jin Lee, Hae-Mi Woo, Ki Wha Chung.

Abstract
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neuropathies and is a genetically and clinically heterogeneous disorder with variable inheritance modes. Since several molecules have been reported to have therapeutic effects on CMT, depending on the underlying genetic causes, exact genetic diagnostics have become very important for executing personalized therapy. Whole-exome sequencing has recently been introduced as an available method to identify rare or novel genetic defects from genetic disorders. Particularly, CMT is a model disease to apply exome sequencing, since more than 50 genes (loci) are involved in its development with weak genotype-phenotype correlation. This study performed the exome sequencing in twenty five unrelated CMT patients who revealed neither 17p12 duplication/deletion nor several major CMT genes. This study identified eight causative heterozygous mutations (32%). This detection rate seems rather high, since each sample was tested before the study for major genetic causes. Therefore, this study suggests that the exome sequencing can be a highly exact, rapid, and economical molecular diagnostic tool for CMT patients who are tested for major genetic causes.

Friday, 27 January 2012

What is a ... "MitoExome"?

The latest issue of Science Translational Medicine reports an article describing the target sequencing of the mitochondrial DNA and exons of 1037 nuclear genes encoding mitochondrial proteins in 42 unrelated infants with clinical and biochemical evidence of mitochondrial oxidative phosphorylation disease. 10 patients had mutations in genes previously linked to disease while 13 had mutations in nuclear genes not previously linked to disease. The pathogenicity of two such genes, NDUFB3 and AGK, was supported by complementation studies and evidence from multiple patient. For the other half of the patients studied, the genetic mutations causing mitochondrial disorders remain unknown.
The study has been carried out by several groups at the Broad Institute, Massachusetts General Hospital, and elsewhere. The team will apply the same technique in adults who develop the disease later in life. Researchers estimate that mutations in more than 200 different mitochondrial genes could give rise to mitochondrial diseases, but to date, only about 100 of these disease genes have been identified.


Saturday, 14 January 2012

Pediatric Cancer Genome Project

Two years ago St. Jude Children's Research Hospital and Washington University School of Medicine in St. Louis announced a $65-million, three-year joint effort to identify the genetic changes that give rise to some of the world's deadliest childhood cancers. The aim was to decode the genomes of more than 600 childhood cancer patients. No one had sequenced a complete pediatric cancer genome prior to the PCGP, which has sequenced more than 250 sets to date.
The project is starting now to produce important results, with two studies published on the latest issue of Nature.
In the first one (The genetic basis of early T-cell precursor acute lymphoblastic leukemia) researchers sequenced the genomes of cancer cells from twelve patients with early T-cell precursor acute lymphoblastic leukemia and discovered that genetically, the subtype had more in common with a different type of leukemia than with other acute lymphoblastic leukemias. This might point the way toward better treatments, according to the St. Jude researchers.
In the other study (A novel retinoblastoma therapy from genomic and epigenetic analyses) investigators sequenced the tumors of four young patients with retinoblastoma, a rare
childhood tumor of the retina of the eye. The finding also led investigators to a new treatment target and possible therapy.

Thursday, 12 January 2012

Flash Report: Cancer Genome and Exome Sequencing in 2011

As a follow-up to his previous post (Disease-causing Mutations Discovered by NGS in 2011) Dan Koboldt compiled for MassGenomics a nice survey of cancer genome and exome sequencing studies published last year.
According to the author around 700 individual tumors representing 17 major cancer types were characterized in the enlisted studies.

Saturday, 31 December 2011

Disease genes identified by NGS in 2011

In the last post of the year on our baby NGS blog, I believe it's worth mentioning the survey performed by Dan Koboldt on Massgenomics about the disease-causing mutations discovered by NGS in 2011. Although the numbers are impressive (60 studies linking genetic variation to mendelian disease) to be honest I thought they were even higher.
However, as the author states at the end of his post "one can only imagine what we’ll know by next December, as large federally-funded initiatives ramp up their efforts to systematically apply exome and whole-genome sequencing to inherited disorders".
I'm sure everybody agrees that 2012 will be a very exciting year for Next Generation Sequencing and Personal Genomics.

Happy ...